Inspire Medical Systems (United States)
company in Maple Grove, United States
INSP NYSE
ISIN US4577301090 SEC CIK 1609550
Follow Inspire Medical Systems (United States)
Weekly email: filings, results
Revenue, last quarter
$206.7M
−7.9% vs same quarter last year
Net income
−$24.4M
−345.6% vs same quarter last year
EPS, diluted
−$0.84
−347.1% vs same quarter last year
Operating cash flow
$46.4M
−32.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $912M | $145.4M |
| FY24 | $802.8M | $53.5M |
| FY23 | $624.8M | −$21.2M |
| FY22 | $407.9M | −$44.9M |
| FY21 | $233.4M | −$42M |
| FY20 | $115.4M | −$57.2M |
| FY19 | $82.1M | −$33.2M |
| FY18 | $50.6M | −$21.8M |
| FY17 | $28.6M | −$17.5M |
| FY16 | $16.4M | −$18.5M |
| FY15 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 85.4% | 5.6% | 15.9% |
| FY24 | 84.7% | 4.5% | 6.7% |
| FY23 | 84.5% | −6.4% | −3.4% |
| FY22 | 83.8% | −11.7% | −11% |
| FY21 | 85.7% | −17.1% | −18% |
| FY20 | 84.7% | −48.7% | −49.6% |
| FY19 | 83.4% | −42.5% | −40.5% |
| FY18 | 80.1% | −40.3% | −43.1% |
| FY17 | 78.9% | −56% | −61.3% |
| FY16 | 76.2% | −105% | −112.8% |
| FY15 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $78.5M |
| FY24 | $91.1M |
| FY23 | $1M |
| FY22 | $2.5M |
| FY21 | −$24.8M |
| FY20 | −$55.5M |
| FY19 | −$35.6M |
| FY18 | −$18.9M |
| FY17 | −$16.2M |
| FY16 | −$18.3M |
| FY15 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $175M |
| FY24 | $0 |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
- Inspire Medical Systems (United States)
- Healthcare median
Show the numbers
| Year | Inspire Medical Systems (United States) | Healthcare median |
|---|---|---|
| FY25 | 15.9% | −30.6% |
| FY24 | 6.7% | −47% |
| FY23 | −3.4% | −58% |
| FY22 | −11% | −80.4% |
| FY21 | −18% | −71.8% |
| FY20 | −49.6% | −62.2% |
| FY19 | −40.5% | −46.2% |
| FY18 | −43.1% | −49.6% |
| FY17 | −61.3% | −45.9% |
| FY16 | −112.8% | −36% |
| FY15 | - | −37.8% |